Chronic neuroinflammation, oxidative stress, and impaired glucose metabolism in the brain are also recognized as contributing factors to disease pathogenesis
Semaglutide is a weight loss drug that targets the glucagon-like peptide-1 (GLP-1), sold by Novo Nordisk under the brand name Wegovy to treat people with obesity and under Ozempic to treat patients with both type 2 diabetes and obesity
Epitalon, marketed as an anti-aging treatment, rests on its ability to lengthen telomeres in human cells the mechanism FDA flagged as a cancer risk, since long telomeres are linked to higher tumor rates, according to Drug Topics
[FOLLICLE STRENGTHENER] Enhances thickness and density by reinforcing weak roots at the cellular level
Similar findings were noted with dipeptidyl peptidase-4 inhibitors in another meta-analysis of 82 RCTs, in which they increased the risk of gallbladder or biliary diseases (OR, 1.22